Location: San Diego, CA
CIK: 0002161353 · Show all filings
Period: Q2 2026 (← Previous) (Next →)
Filing Date: Nov 3, 2026
Total Value: $3.191M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| SCHX | Schwab US Large-Cap ETF | 32,891 | $968K | 30.3% | $29.43 | $26.71 | +10.2% | US LRG CAP ETF | 808524201 |
| QUAL | iShares MSCI USA Quality Factor ETF | 1,943 | $426K | 13.4% | $219.41 | $196.49 | +11.7% | MSCI USA QLT FCT | 46432F339 |
| ZNTL | Zentalis Pharmaceuticals Inc | 86,017 | $417K | 13.1% | $4.85 | $1.46 | +233.2% | COM | 98943L107 |
| VUG | Vanguard Growth Index Fund ETF Shares | 3,084 | $266K | 8.3% | $86.14 | $83.64 | +3.0% | MRNGSTR GRWT ETF | 922908736 |
| IMNM | Immunome Inc | 10,587 | $224K | 7.0% | $21.19 | $17.55 | +20.7% | COM | 45257U108 |
| AMZN | Amazon.com Inc | 912 | $217K | 6.8% | $238.34 | $251.01 | -5.0% | COM | 023135106 |
| — | GAMCO Natural Resources Gold & Income Trust | 20,212 | $165K | 5.2% | $8.15 | $7.45 | — | SH BEN INT | 36465E101 |
| — | Morgan Stanley Emerging Markets Domestic Debt Fund, Inc | 23,510 | $138K | 4.3% | $5.88 | $5.43 | — | COM | 617477104 |
| — | Templeton Emerging Markets Income Fund | 18,500 | $125K | 3.9% | $6.74 | $6.45 | — | COM | 880192109 |
| — | GAMCO Global Gold, Natural Resources & Income Trust | 23,803 | $115K | 3.6% | $4.84 | $5.16 | — | COM SH BEN INT | 36465A109 |
| — | Saba Capital Income & Opportunities Fund II | 12,250 | $102K | 3.2% | $8.35 | $8.25 | — | COM | 880198205 |
| FATE | Fate Therapeutics Inc | 10,000 | $27,000 | 0.8% | $2.70 | $1.20 | +124.9% | COM | 31189P102 |